Related Experiment Video
Updated: Jan 20, 2026
High-Throughput Robotically Assisted Isolation of Temperature-sensitive Lethal Mutants in Chlamydomonas reinhardtii
Published on: December 5, 2016
The increasing impact of lethal mutagenesis of viruses
Celia Perales1,2,3, Isabel Gallego2,3, Ana Isabel de Ávila3
1Department of Clinical Microbiology, IIS-Fundación Jiménez Díaz, UAM. Av. Reyes Católicos 2, 28040, Madrid, Spain.
Abstract:
Selection of viral mutants resistant to compounds used in therapy is a major determinant of treatment failure, a problem akin to antibiotic resistance in bacteria. In this scenario, mutagenic base and nucleoside analogs have entered the picture because they increase the mutation rate of viral populations to levels incompatible with their survival. This antiviral strategy is termed lethal mutagenesis. It has found a major impulse with the observation that some antiviral agents, which initially were considered only inhibitors of virus multiplication, may in effect exert part of their antiviral activity through mutagenesis. Here, we review the conceptual basis of lethal mutagenesis, the evidence of virus extinction through mutagenic nucleotide analogs and prospects for application in antiviral designs.
Insights
Lethal mutagenesis uses mutagenic compounds to increase viral mutation rates, leading to virus extinction. This strategy offers a novel approach to antiviral therapy, combating treatment resistance.
Area of Science:
- Virology
- Molecular Biology
- Drug Discovery
Background:
- Viral resistance to antiviral drugs is a significant challenge in treatment, similar to bacterial antibiotic resistance.
- Mutagenic base and nucleoside analogs can elevate viral mutation rates to lethal levels.
- Some antiviral agents may possess mutagenic properties contributing to their efficacy.
Purpose of the Study:
- To review the fundamental principles of lethal mutagenesis as an antiviral strategy.
- To examine evidence supporting virus extinction via mutagenic nucleotide analogs.
- To explore the potential applications of lethal mutagenesis in future antiviral drug design.
Main Methods:
- Review of existing literature on lethal mutagenesis and antiviral drug resistance.
- Analysis of studies demonstrating virus extinction induced by mutagenic nucleotide analogs.
- Conceptual exploration of antiviral therapy mechanisms.
Main Results:
- Lethal mutagenesis is a viable strategy for inducing viral extinction by overwhelming mutation rates.
- Mutagenic nucleotide analogs have demonstrated efficacy in reducing viral populations.
- The mutagenic activity of certain antiviral drugs contributes to their therapeutic effect.
Conclusions:
- Lethal mutagenesis presents a promising avenue for developing novel antiviral therapies.
- Further research into mutagenic nucleotide analogs could lead to new drug designs.
- Understanding and harnessing viral mutagenesis is key to overcoming antiviral resistance.
Related Concept Videos
10:51High-Throughput Robotically Assisted Isolation of Temperature-sensitive Lethal Mutants in Chlamydomonas reinhardtii
04:51Optogenetic Random Mutagenesis Using Histone-miniSOG in C. elegans
02:41Lethal Alleles
Lucien Cuénot discovered lethal alleles in 1905 while studying the inheritance of coat color in mice. The agouti gene is responsible for the color of the coat in mice. This gene codes for an agouti-signaling protein, which is responsible for melanin distribution in mammals. The wild-type allele gives rise to gray-brown coat color in mice, while the mutant allele gives rise to yellow coat color. In addition to coat color, the agouti gene is associated with the yellow...
07:40A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions
01:16In-vitro Mutagenesis
00:50What are Viruses?